Walker J. Magrath

Walker J. Magrath

Auto-generated profile, based on publicly available information

Walker J. Magrath

The Johns Hopkins University School of Medicine, Baltimore, Maryland (W.J.M.).

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
AWAlexandra Wallimann
Alexandra Wallimann
WMWalker Magrath
Walker Magrath
BPBrenna Pugliese
Brenna Pugliese
NSNino Stocker
Nino Stocker
PWPatrick Westermann
Patrick Westermann
Fintan  MoriartyFintan Moriarty
Fintan Moriarty
Short‐chain fatty acids (SCFAs) produced by the gut microbiota have previously been demonstrated to play a role in numerous chronic inflammatory diseases and to be key mediators in the gut‐bone signaling axis. However, the role of SCFAs in bone fracture healing and its impact on systemic inflammation during the regeneration process has not been extensively investigated yet. The aim of this study was to first determine the effects of the SCFA butyrate on key cells involved in fracture healing in vitro, namely, osteoclasts and mesenchymal stromal cells (MSCs), and second, to assess if butyrate supplementation or antibiotic therapy impacts bone healing, systemic immune status, and inflammation levels in a murine osteotomy model. Butyrate significantly reduced osteoclast formation and resorption activity in a dose‐dependent manner and displayed a trend for increased calcium deposits in MSC cultures. Numerous genes associated with osteoclast differentiation were differentially expressed in osteoclast precursor cells upon butyrate exposure. In vivo, antibiotic‐treated mice showed reduced SCFA levels in the cecum, as well as a distinct gut microbiome composition. Furthermore, circulating proinflammatory TNFα, IL‐17a, and IL‐17f levels, and bone preserving osteoprotegerin (OPG), were increased in antibiotic‐treated mice compared to controls. Antibiotic‐treated mice also displayed a trend towards delayed bone healing as revealed by reduced mineral apposition at the defect site and higher circulating levels of the bone turnover marker PINP. Butyrate supplementation resulted in a lower abundance of monocyte/macrophages in the bone marrow, as well as reduced circulating proinflammatory IL‐6 levels compared to antibiotic‐ and control‐treated mice. In conclusion, this study supports our hypothesis that SCFAs, in particular butyrate, are important contributors to successful bone healing by modulating key cells involved in fracture healing as well as systemic inflammation and immune responses.

1 October 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
WMWalker J. Magrath
Walker J. Magrath
Johns Hopkins Hospital established the first gender-affirming surgery (GAS) clinic in the United States in 1966. Its abrupt closure in 1979 was attributed to objective evidence claiming that GAS wa... Johns Hopkins Hospital established the first gender-affirming surgery (GAS) clinic in the United States in 1966. Operating for more than 13 years, the clinic was abruptly closed in 1979. According ...

7 June 2022 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
WMWalker J. Magrath
Walker J. Magrath
MSMatthew Shneyderman
Matthew Shneyderman
TBTom K. Bauer
Tom K. Bauer
PNPaula Neira
Paula Neira
SBSimon Best
Simon Best
LALee M. Akst
Lee M. Akst

23 May 2022 in Face
Verified
Journal Article
Closed access
JPJoseph S. Puthumana
Joseph S. Puthumana
CLChristopher D. Lopez
Christopher D. Lopez
WMWalker J. Magrath
Walker J. Magrath
ILIsabel V. Lake
Isabel V. Lake
AGAlisa O. Girard
Alisa O. Girard
RYRobin Yang
Robin Yang
Background: This study aims to investigate all papers on orthognathic fixation to better understand changes in operative techniques and fixation materials and to better compare relapse and complication rates. Methods: A PubMed search was conducted of “orthognathic” AND “fixation” in the title or abstract between 1989 and 2020. Results: Three reviewers independently screened 439 papers and extracted data from 166 included papers. Of these studies, 118 investigated sagittal split ramus osteotomies (SSRO), 96 LeFort osteotomies, 25 genioplasties, and 21 intraoral vertical ramus osteotomies (IVRO). The most used fixation materials in the maxilla were titanium miniplates with monocortical screws (n = 65), followed by resorbable miniplates (n = 10); in the mandible, the most common were titanium miniplates (n = 67) and titanium bicortical screws (n = 49). Wide variability was demonstrated in relapse rates by operation, fixation type, and relapse time-point studied. Meta-analysis revealed a significantly higher infection rate in SSRO versus LeFort ( P = .003) and, surprisingly, a trend toward higher relapse rate in titanium versus resorbable fixation at 6 months in SSRO setback ( P = .08). Conclusion: This study reports all the available data on relapse rates across techniques, with non-inferiority of bicortical screws versus miniplates.